Doutor Revela:
3 alimentos que estão matando seu fígado (O #3 vai te chocar)
1 - Vrentzos et al., 2024. Six-month supplementation with high dose coenzyme Q10
improves liver steatosis, endothelial, vascular and myocardial function in patients
with metabolic-dysfunction associated steatotic liver disease: a randomized
double-blind, placebo-controlled trial.
2 - Farsi et al., 2016. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
3 - Langsjoen & Langsjoen, 2014. Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone.
4 - Ates et al., 2013. Plasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy.
5 - Alehagen et al., 2013. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.
6 - Mato et al., 1999. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.
2 - Farsi et al., 2016. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
3 - Langsjoen & Langsjoen, 2014. Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone.
4 - Ates et al., 2013. Plasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy.
5 - Alehagen et al., 2013. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.
6 - Mato et al., 1999. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.